 Home > Medical News > Latest Medical News > AstraZeneca and Inovio terminate 6-year DNA cancer vaccine collaboration

AstraZeneca and Inovio terminate 6-year DNA cancer vaccine collaboration

 Last Update: 2021-12-09
 Source: Internet
 Author: User

Tags

human cell

year charlotte

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

CompilationFan Dongdong

A few days ago, it was reported that AstraZeneca and Inovio had signed a six-year cooperation development agreement with human papillomavirus-related DNA cancer vaccines, which has been cancelled

In a document published by the US Securities Exchange, Inovio announced that AstraZeneca's Medimmune Limited has terminated the development plan of INO-3112, which is a vaccine candidate called MEDI0457

When the two biotech companies first reached a deal in 2015, Medimmune acquired the rights to INO-3112, a drug designed to target cancers caused by human papillomavirus types 16 and 18

INO-3112's cancellation of cooperation does not mean that the two companies have completely disconnected.

In addition, Inovio has also made progress in the ongoing battle against COVID-19 and other infectious diseases

In terms of COVID-19, Inovio has advanced its vaccine candidate to phase III studies

At the same time, the vaccine has also received support from the World Health Organization (WHO) and approved its Phase III trials in Colombia, the Philippines and Mali

Reference source: Inovio and AstraZeneca Terminate Six-Year-Old DNA Cancer Vaccine Program

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

80 20 company(94)

united states logo(227)

ups united states(221)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.